Labiotech.eu

In Depth 2 Nov 2023

How French pharma giant Sanofi is betting big on AI

The benefits of artificial intelligence (AI) in shaping clinical research and trials have given rise to many new AI-driven biotech startups. According to a recent report, the number of AI companies involved in drug discovery and development increased from 62 in 2011 to 400 in 2022. This AI-driven transformation is catching the attention of big pharma […]

November 2, 2023 - 8 minutesmins - By Willow Shah-Neville

Opinion 1 Nov 2023

Could this be the start of a new era for PI3K drugs?

There is hope that a rich biotech pipeline will produce a second generation of PI3K drugs, a type of kinase inhibitor, after issues with the first generation from the class had brought up concerns. Phosphoinositide 3-kinases (PI3K) drugs work by inhibiting a pathway that plays a role in cell metabolism, growth, proliferation and survival that […]

November 1, 2023 - 7 minutesmins - By External Contributor

Best in Biotech 31 Oct 2023

Six biotech companies in Melbourne that have been making the news

Located on the southeastern coast of Australia, Melbourne is one of the leading life science hubs in the Asia Pacific region, according to a CBRE report published in 2021. With more and more investors taking an interest in the Melbourne region, this contributes to the country’s market value of $170 billion in the sector, with […]

October 31, 2023 - 9 minutesmins - By Roohi Mariam Peter

In Depth 30 Oct 2023

The ongoing search for an HIV cure: can CRISPR crack the code?

HIV continues to represent a global health burden, with the World Health Organization (WHO) estimating that, in 2022, there were 39 million people living with the virus. But there is still no effective cure for it. The only option patients have is antiretroviral therapy, which, although it represents a major milestone in HIV treatment and […]

October 30, 2023 - 7 minutesmins - By Willow Shah-Neville

In Depth 27 Oct 2023

Big pharma monopolies: major antitrust cases over the past decade

Antitrust laws are put in place to prevent unlawful activities like price fixing, as well as monopolies from forming, typically tied to big pharma. If these powerful companies were to swallow smaller biotechs in an attempt to fix prices, it would stifle competition, result in limited options for consumers, thereby leading to a rise in […]

October 27, 2023 - 11 minutesmins - By Roohi Mariam Peter

Podcast 27 Oct 2023

Beyond Biotech podcast 69 – improving access to cell and gene therapy

This week, our guest on the podcast is Jason C. Foster, CEO of Ori Biotech. Ori is a London, U.K. and New Jersey, U.S. based manufacturing technology company pioneering flexible process discovery with translation and scalable commercialization of cell and gene therapies (CGT), increasing access to these innovative treatments. Ori has developed a proprietary, full […]

October 27, 2023

In Depth 26 Oct 2023

Behind closed doors: The unseen controversies and scandals in Alzheimer’s drug trials

Alzheimer’s disease is the most common form of dementia – which currently affects more than 55 million people globally – making up 60% to 70% of cases. It is a complex disease, encompassing multiple interrelated and progressive destructive processes in the brain, resulting in neuron damage that extends to parts of the brain that enable […]

October 26, 2023 - 11 minutesmins - By Willow Shah-Neville

Opinion 25 Oct 2023

Microbiome: are we ready for third generation live biotherapeutics?

The microbiome sector has come a long way. From liquidizing fecal matter in a kitchen appliance for direct insertion into the intestine to the encapsulation of dried matter for oral delivery; and now to the creation of live biotherapeutics, single drug products of multiple bacterial strains. The application of microbiome therapeutics is also broadening – […]

October 25, 2023 - 11 minutesmins - By External Contributor

Best in Biotech 24 Oct 2023

Seven molecular glue startups looking to stick around in the biotech industry

Since they were discovered around three decades ago, molecular glues have come a very long way as a therapeutic option for several different disease areas, including cancer and neurodegenerative disorders. Now, there are a rising number of molecular glue companies hoping to show clinical success with their candidates. The term molecular glue refers to a […]

October 24, 2023 - 9 minutesmins - By Willow Shah-Neville

Top 10 tips on how to start an early phase clinical trial

Expert Advice 23 Oct 2023

Top 10 tips from an expert on how to start an early phase clinical trial

Early phase clinical trials can be complicated and time-consuming, with their success dependent on several different factors. The outcome of these early phase clinical trials will determine the future of your drug development project, and so ensuring safety and efficiency at every step since the start is vital for its overall success. The clinical operations […]

October 23, 2023 - 8 minutesmins - By External Contributor

In Depth 20 Oct 2023

Is Africa ready to become the next big biopharma and vaccine manufacturing destination?

Localizing pharma manufacturing worldwide is an extremely important step, and it holds particular significance for Africa. The continent is more vulnerable to disease burdens and lags behind other continents when it comes to vaccine and general healthcare access. Localized manufacturing could help people in Africa gain easier and more affordable access to vaccines and other […]

October 20, 2023 - 10 minutesmins - By Willow Shah-Neville

induced pluripotent stem cells ipsc Alzheimer's

Podcast 20 Oct 2023

Beyond Biotech podcast 68 – rejuvenation with stem cells

This week, our guest on the podcast is Mark Kotter, founder of clock.bio. clock.bio, a sister company to bit.bio, which Kotter also founded and is the CEO of, aims to extend and improve quality of life by reversing the harmful effects of time in our cells, harnessing the regenerative capabilities of human pluripotent stem cells […]

October 20, 2023

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

How French pharma giant Sanofi is betting big on AI

Could this be the start of a new era for PI3K drugs?

Six biotech companies in Melbourne that have been making the news

The ongoing search for an HIV cure: can CRISPR crack the code?

Big pharma monopolies: major antitrust cases over the past decade

Beyond Biotech podcast 69 – improving access to cell and gene therapy

Behind closed doors: The unseen controversies and scandals in Alzheimer’s drug trials

Microbiome: are we ready for third generation live biotherapeutics?

Seven molecular glue startups looking to stick around in the biotech industry

Top 10 tips from an expert on how to start an early phase clinical trial

Is Africa ready to become the next big biopharma and vaccine manufacturing destination?

Beyond Biotech podcast 68 – rejuvenation with stem cells

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!